Dr. Ute Berger

Dr. Ute Berger, MD, currently serves as President of ICON Development & Commercialisation Solutions at ICON plc since September 2022, overseeing various initiatives including Decentralised Clinical Trial Solutions and Consulting Services. Prior to this role, Dr. Berger held multiple senior leadership positions at PRA Health Sciences from January 2006 to September 2022, culminating in the role of Senior Vice President of Medical & Scientific Affairs, where responsibilities included Pharmacovigilance and Patient Safety. Dr. Berger’s educational background includes a Doctor of Medicine degree from the University of Heidelberg, Germany, with board certifications in Internal Medicine, Hematology, and Medical Oncology.